Clinical Trial Update: Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the FLAC chemotherapy regimen in combination with GM-CSF for locally advanced and metastatic breast cancer; the study status is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FLAC chemotherapy regimen
• Sargramostim (GM-CSF) (sargramostim)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer, Breast Neoplasms | Phase 2 | Status: COMPLETED